WYLIE L. OVERLY, M.D.; JOSEPH A. DANKOFF, B.S.; BARBARA K. WANG, M.D.; USHA D. SINGH, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: An association between primary hepatic tumors and androgen therapy was first noted in 1965 (1). In a recent review of the literature, 33 cases of patients with androgen-associated hepatic tumors were reported (2); 14 of these patients had received androgens as therapy for Fanconi's anemia, and 19 patients, for various other, potentially androgen-responsive illnesses. We have recently cared for a young man who developed a primary hepatic malignancy after taking androgens to increase his skeletal muscle mass. This patient represents the first reported case of such a malignancy in an otherwise healthy athlete taking androgens for this
OVERLY WL, DANKOFF JA, WANG BK, et al. Androgens and Hepatocellular Carcinoma in an Athlete. Ann Intern Med. 1984;100:158–159. doi: 10.7326/0003-4819-100-1-158_3
Download citation file:
Published: Ann Intern Med. 1984;100(1):158-159.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use